Home › M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down
 

Keywords :   


M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down

2015-12-14 20:08:05| Biotech - Topix.net

Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty.

Tags: small slowing midcap biotechs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
01.07Atlantic Tropical Weather Outlook
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 9A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Depression Three Graphics
01.07Tropical Depression Three Public Advisory Number 1A
01.07Summary for Tropical Depression Three (AT3/AL032024)
01.07Eastern North Pacific Tropical Weather Outlook
More »